Navidea Biopharmaceuticals Announces First Quarter 2013 Results

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced business highlights and consolidated results for the first quarter ended March 31, 2013.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC